Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension
Sponsor: Retension Pharmaceuticals. Inc.
Summary
The purpose is to determine the effective dosage and to study the effects of this dosage taken for 12 days on systolic and diastolic blood pressure in patients with hypertension.
Official title: A Pilot Phase IIa Randomised, Double-blind, Placebo-controlled, Crossover Study to Examine the Safety, Tolerability and Pharmacodynamic Effects on Blood Pressure of Repeat Oral Doses of SLx-2101 5, 10 or 20 mg Once Daily for up to 14 Days in Patients With Hypertension
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2007-07
Completion Date
2007-12
Last Updated
2026-04-30
Healthy Volunteers
No
Conditions
Interventions
SLx-2101
Locations (1)
Addenbrooke's Hospital
Cambridge, United Kingdom